Tissue and Cell Extraction and Purification

EP10011 100 Tests
EUR 444.6

Biotium Laboratories manufactures the biiotium reagents distributed by Genprice. The Biiotium reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Biotium. Other Biiotium products are available in stock. Specificity: Biiotium Category:

True Blue Chloride

100mg
EUR 11200
Description: 71431-30-6

True north Cryobox1.5/2mLNatural

PK10
EUR 129.6

True Blue Diaceturate Salt

100mg
EUR 15000
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

1mg Ask for price
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

5mg Ask for price
Description: 108321-12-6

Porcine True insulin ELISA kit

96T
EUR 700
Description: ELISA

Goat True insulin ELISA kit

96T
EUR 700
Description: ELISA

Test Assays information

BIIL 260

MBS5776536-5x5mg 5x5(mg
EUR 3970

BIIL 260

T26809-10mg 10mg Ask for price
Description: BIIL 260

BIIL 260

T26809-1g 1g Ask for price
Description: BIIL 260

BIIL 260

T26809-1mg 1mg Ask for price
Description: BIIL 260

BIIL 260

T26809-50mg 50mg Ask for price
Description: BIIL 260

BIIL 260

T26809-5mg 5mg Ask for price
Description: BIIL 260

BIIB021

A4058-10 10 mg
EUR 64
Description: Metabolism|HSP#Proteases|HSP

BIIB021

A4058-100 100 mg
EUR 256
Description: Metabolism|HSP#Proteases|HSP

BIIB021

A4058-5 5 mg
EUR 44
Description: Metabolism|HSP#Proteases|HSP

BIIB021

A4058-5.1 10 mM (in 1mL DMSO)
EUR 48.8
Description: Metabolism|HSP#Proteases|HSP

BIIB021

A4058-50 50 mg
EUR 168
Description: Metabolism|HSP#Proteases|HSP

BIIB068

462609 50.0mg
EUR 950

BIIB021

27046 5 mg
EUR 130
Description: BIIB021 is an orally available, synthetic small-molecule Hsp90 inhibitor. It binds in the ATP-binding pocket of Hsp90 (Ki = 1.7 ± 0.4 nM) and induces HER-2 degradation with an EC50 of 38 ± 10 nM in MCF-7 cells. It ncreases expression of the heat shock proteins Hsp90α and Hsp70, but has no effect on expression of the nonclient protein phosphatidylinositol 3-kinase p85 subunit. BIIB021 inhibits the proliferation of N87, MCF-7, and BT474 tumor cells with IC50 values of 0.06, 0.31, and 0.14 µM, respectively. It has significant antitumor activity in N87 stomach, BT474 breast, CWR22 prostate, U87 glioblastoma, SKOV3 ovarian, and Panc-1 pancreatic tumor xenograft models.

BIIB021

200505 10.0mg
EUR 150

Biib-021

abx188616-1g 1 g
EUR 910.8

BIIB021

abx188616-96tests 96 tests
EUR 118.75

BIIB021

HY-10212 50mg
EUR 250
Description: BIIB021 (CNF2024) is an orally active, fully synthetic inhibitor of HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively[1].